Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized double-blind trial of CA-702 in primary Sjogren's syndrome with xerostomia
jRCT2073210083Phase 2Recruiting
- Sponsor
- CellAxia
- Start
- Oct 2021
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Sjögren's syndrome (SS) comparing CA-702 with Placebo (2 arms). Started Oct 2021; status: recruiting.
02
Drugs
CA-702
03
Conditions
Sjögren's syndrome (SS)
Beyond the preview
Go deeper on jRCT2073210083.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2073210083.